David Wells

David Wells currently serves as Chief Business Officer at Alafair Biosciences, Inc. since May 2024, following a tenure as President - US at Neo Medical from September 2022 to May 2024. Previously, David held various roles at NuVasive from 2012 to 2022, including Senior Marketing Manager for the Western Region, where responsibilities included acting as a corporate liaison and driving growth initiatives for thoracolumbar products. David's notable achievements with NuVasive include exceeding sales quotas and significantly increasing territory revenue. Earlier in David's career, experience includes sales positions at Medtronic Spine & Biologics and Novartis, garnering multiple awards for sales performance. David holds an MBA from USC Marshall School of Business and a Bachelor of Arts in Strategic Communication from The Ohio State University.